%0 Journal Article %A Seungwoo Cha %A Sherry L Grace %A Kyungdo Han %A Bongseong Kim %A Nam-Jong Paik %A Won-Seok Kim %T Effect of physical inactivity and tobacco use on mortality and morbidity in revascularized patients with peripheral arterial disease: A nationwide cohort study %D 2021 %R 10.1101/2021.05.12.21257135 %J medRxiv %P 2021.05.12.21257135 %X Importance Physical activity (PA) and tobacco use are key health behaviours in patients with peripheral arterial disease (PAD). Limited studies are available on effects of those behaviours in PAD after revascularization, including Asian countries where tobacco use is high.Objective To investigate the effects of PA and tobacco use on adverse clinical outcomes in patients with PAD after revascularization.Design Retrospective cohort studySetting Population-based study using the Korean National Health Insurance Service (NHIS) databaseParticipants Patients who had received revascularization for PAD between 2010-2015 were included. They were categorized as active or inactive based on the number of days per week they engaged in PA and as current or non-tobacco users (self-report).Exposures PA and tobacco use.Main outcomes The primary outcome was all-cause mortality. Secondary outcomes included major adverse outcome (a composite of all-cause mortality, myocardial infarction, and stroke) and major adverse limb event (MALE, a composite of amputation and recurrent revascularization).Results The cohort comprised 8324 patients (mean age, 64.7 years; 76.9% male). Among them, 32.7% were inactive and 26.4% were tobacco users. Active patients had significantly better outcomes than inactive patients [all-cause mortality adjusted hazard ratio (adjHR) = 0.766 (0.685 – 0.855), major adverse outcome adjHR = 0.795 (0.719 – 0.878), MALE adjHR = 0.858 (0.773 – 0.953)]. Tobacco users had significantly poorer outcomes than non-users [all-cause mortality adjHR = 1.279 (1.124 – 1.456), major adverse outcome adjHR = 1.263 (1.124 – 1.418), MALE adjHR = 1.291 (1.143 – 1.458)].Conclusions and Relevance Even after receiving revascularization for PAD, a sizable proportion of patients were inactive and used tobacco, leading to adverse clinical outcomes. These modifiable risk factors are systematically addressed in cardiac rehabilitation; in line with current guideline recommendations, more needs to be done to ensure cardiac rehabilitation participation in patients with PAD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by a Seoul National University Bundang Hospital Research Fund (06-2020-153) received by Kim W-S.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was exempt from review by the Seoul National University Bundang Hospital Institutional Review Board (IRB number X-2001-591-901), complying with the requirements of the Declaration of Helsinki. Data from the Korean NHIS were fully anonymized for analyses, and the need for informed consent was waived.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are available through the Korean National Health Insurance Sharing Service. Researchers who wish to access the data should apply on the website (https://nhiss.nhis.or.kr/bd/ay/bdaya001iv.do) and request access to NHIS-2020-1-339. %U https://www.medrxiv.org/content/medrxiv/early/2021/05/15/2021.05.12.21257135.full.pdf